Cell Nutrition

Tissue Engineering

Volumn , Issue , 2008, Pages 327-362

  Malda, Jos ^a   Radisic, Milica ^b   Levenberg, Shulamit ^c   Woodfield, Tim ^d   Oomens, Cees ^e   Baaijens, Frank ^e   Svalander, Peter ^f   Vunjak Novakovic, Gordana ^g  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b UNIVERSITY OF TORONTO   (Canada)

^c TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^d UNIVERSITY OF TWENTE   (Netherlands)

^e EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

^f Swedish Biotechnology AB   (Sweden)

^g Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CELL PROLIFERATION; HISTOLOGY; MASS TRANSFER; TISSUE; TISSUE ENGINEERING;

CELL CULTURE MEDIUMS; CELLULAR PROLIFERATIONS; INTERNAL MASS TRANSFER; MEDIUM COMPOSITION; NUTRIENT GRADIENTS; NUTRIENT LIMITATIONS; NUTRIENT REQUIREMENT; TISSUE ENGINEERED CONSTRUCTS;

NUTRIENTS;

EID: 84863438481     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-370869-4.00012-4     Document Type: Chapter

References (97)

1. Arnold J. Über Theilungsvorgänge an der Wanderzellen: ihre progressiven und regressiven Metamorphosen. Arch Mikrosk Anat 1887, 30:205-310.
2. Bancroft G.N., Sikavitsas V.I., et al. Design of a flow perfusion bioreactor system for bone tissue-engineering applications. Tissue Engineering 2003, 9(3):549-554.
3. Belay E.D., Schonberger L.B. The public health impact of prion diseases. Annu Rev Public Health 2005, 26:191-212.
4. Bialek W., Botstein D. Introductory science and mathematics education for 21st-Century biologists. Science 2004, 303(5659):788-790.
5. Bibby S.R., Jones D.A., et al. Metabolism of the intervertebral disc: effects of low levels of oxygen, glucose, and pH on rates of energy metabolism of bovine nucleus pulposus cells. Spine 2005, 30(5):487-496.
6. Black A.F., Berthod F., et al. In vitro reconstruction of a human capillary-like network in a tissue-engineered skin equivalent. Faseb J 1998, 12(13):1331-1340.
7. Bursac N., Papadaki M., et al. Cardiac muscle tissue engineering: toward an in vitro model for electrophysiological studies. Am J Physiol 1999, 277(2 Pt 2):H433-H444.
8. Bursac N., Papadaki M., et al. Cultivation in rotating bioreactors promotes maintenance of cardiac myocyte electrophysiology and molecular properties. Tiss Eng 2003, 9(6):1243-1253.
9. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003, 9(6):653-660.
10. Carmeliet P., Jain R.K. Angiogenesis in cancer and other diseases. Nature 2000, 407(6801):249-257.
11. Carrel A., Lindbergh C. The culture of whole organs. Science 1935, 81(2112):621-623.
12. Carrier R., Papadaki M., et al. Cardiac tissue engineering: cell seeding, cultivation parameters, and tissue construct characterization. Biotechnol Bioeng 1999, 64(5):580-589.
13. Carrier R., Rupnick M., et al. Perfusion improves tissue architecture of engineered cardiac muscle. Tiss Eng 2002, 8(2):175-188.
14. Casey T.M., Arthur P.G. Hibernation in noncontracting mammalian cardiomyocytes. Circulation 2000, 102(25):3124-3129.
15. Colton C. Implantable biohybrid artificial organs. Cell Transplant 1995, 4(4):415-436.
16. Crabtree H. Observations on the carbohydrate metabolism of tumours. Biochem J 1929, 23:536-545.
17. Doran P. Bioprocess Engineering Principles 2000, Academic Press, London.
18. Dulbecco R., Freeman G. Plaque production by the polyoma virus. Virology 1959, 8:396-397.
19. Eagle H. myo-Inositol as an Essential Growth Factor for Normal and Malignant Human Cells in Tissue Culture. J Biol Chem 1956, 214:845-847.
20. Eagle H. Amino acid metabolism in mammalian cell cultures. Science 1959, 130:432-437.
21. Earle W. Production of Malignancy In Vitro. IV. The mouse fibroblast cultures and changes seen in the living cells. JNCI 1943, 4:165-169.
22. Ehrbar M., Djonov V.G., et al. Cell-demanded liberation of VEGF121 from fibrin implants induces local and controlled blood vessel growth. Circ Res 2004, 94(8):1124-1132.
23. 2 stimulation of mitochondrial adenosine triphosphatase activity. J Biol Chem 1963, 238:836-842.
24. Fidkowski C., Kaazempur-Mofrad M.R., et al. Endothelialized microvasculature based on a biodegradable elastomer. Tiss Eng 2005, 11(1-2):302-309.
25. Freed L.E., Marquis J.C., et al. Composition of Cell-Polymer Cartilage Implants. Biotech Bioeng 1994, 43(7):605-614.
26. Freed L.E., Vunjak-Novakovic G. Spaceflight bioreactor studies of cells and tissues. Adv Space Biol Med 2002, 8:177-195.
27. Goldstein A., Juarez T., et al. Effect of convection on osteoblastic cell growth and function in biodegradable polymer foam scaffolds. Biomaterials 2001, 22(11):1279-1288.
28. Ham R. An improved Nutrient Solution for Diploid Chinese Hamster and Human Cell Lines. Exp Cell Res 1963, 29:515-526.
29. Ham R. Cell growth requirements - the challenge we face. The growth requirements of vertebrate cells in vitro 1981, 1-15. Cambridge University Press, Cambridge. C. Waymouth, R. Ham, P. Chapple (Eds.).
30. Hanks J., Wallace R. Relation of oxygen and temperature in the preservation of tissues by refrigeration. Proc Soc Exp Biol Med 1949, 71:196-200.
31. Harimoto M., Yamato M., et al. Novel approach for achieving double-layered cell sheets co-culture: overlaying endothelial cell sheets onto monolayer hepatocytes utilizing temperature-responsive culture dishes. J Biomed Mater Res 2002, 62(3):464-470.
32. Harrison R. Experiments in transplanting limbs and their bearings on the problems of the development of nerves. J Exp Zool 1907, 4:239-281.
33. Hastings B., Longmore W. Carbon dioxide and pH as regulatory factors in metabolism. Adv Enzyme Reg 1965, 3:147-159.
34. Higuchi K. Cultivation of animal cells in chemically defined media, a review. Advances in Applied Microbiology 1973, 16:111-136.
35. Horner H., Urban J. Effect of nutrient supply on the viability of cells from the nucleus pulposus of the intervertebral disc. Spine 2001, 26(23):2543-2549.
36. Hubbell J.A. Bioactive biomaterials. Curr Opin Biotechnol 1999, 10(2):123-129.
37. Hutmacher D.W. Scaffolds in tissue engineering bone and cartilage. Biomaterials 2000, 21(24):2529-2543.
38. Jakob M., Demarteau O., et al. Specific growth factors during the expansion and redifferentiation of adult human articular chondrocytes enhance chondrogenesis and cartilaginous tissue formation in vitro. J Cell Biochem 2001, 81(2):368-377.
39. Kaihara S., Borenstein J., et al. Silicon micromachining to tissue engineer branched vascular channels for liver fabrication. Tiss Eng 2000, 6(2):105-117.
40. Kellner K., Liebsch G., et al. Determination of oxygen gradients in engineered tissue using a fluorescent sensor. Biotechnol Bioeng 2002, 80(1):73-83.
41. Lammert E., Cleaver O., et al. Induction of pancreatic differentiation by signals from blood vessels. Science 2001, 294(5542):564-567.
42. Levenberg S., Huang N.F., et al. Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds. Proc Natl Acad Sci USA 2003, 100(22):12741-12746.
43. Levenberg S., Rouwkema J., et al. Engineering vascularized skeletal muscle tissue. Nat Biotechnol 2005, 23(7):879-884.
44. Lewis M.C., MacArthur B.D., et al. Heterogeneous proliferation within engineered cartilaginous tissue: the role of oxygen tension. Biotechnol Bioeng 2005, 91(5):607-615.
45. Lu L., Zhu X., et al. Biodegradable polymer scaffolds for cartilage tissue engineering. Clin Orthop 2001, 391(Suppl):S251-S270.
46. Lutolf M.P., Hubbell J.A. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol 2005, 23(1):47-55.
47. MacArthur B.D., Oreffo R.O. Bridging the gap. Nature 2005, 433(7021):19.
48. Malda J., Martens D.E., et al. Cartilage tissue engineering: controversy in the effect of oxygen. Crit Rev Biotechnol 2003, 23(3):175-194.
49. Malda J., Rouwkema J., et al. Oxygen gradients in tissue-engineered Pegt/Pbt cartilaginous constructs: Measurement and modeling. Biotechnol Bioeng 2004, 86(1):9-18.
50. Malda J., Woodfield T.B., et al. The effect of PEGT/PBT scaffold architecture on oxygen gradients in tissue engineered cartilaginous constructs. Biomaterials 2004, 25(26):5773-5780.
51. Malda J., Woodfield T.B., et al. The effect of PEGT/PBT scaffold architecture on the composition of tissue engineered cartilage. Biomaterials 2005, 26(1):63-72.
52. Marshall, A.J., Barker, T., et al. (2004). Pore size controls angiogenesis in subcutaneously implanted porous matrices. Proc. 7th World Biomaterials Congress, Sydney.
53. Martin I., Obradovic B., et al. Method for quantitative analysis of glycosaminoglycan distribution in cultured natural and engineered cartilage. Ann Biomed Eng 1999, 27(5):656-662.
54. Martin I., Suetterlin R., et al. Enhanced cartilage tissue engineering by sequential exposure of chondrocytes to FGF-2 during 2D expansion and BMP-2 during 3D cultivation. J Cell Biochem 2001, 83(1):121-128.
55. Martin I., Suetterlin R., et al. Enhanced cartilage tissue engineering by sequential exposure of chondrocytes to FGF-2 during 2D expansion and BMP-2 during 3D cultivation. J Cell Biochem 2001, 83(1):121-128.
56. Martin I., Vunjak-Novakovic G., et al. Mammalian chondrocytes expanded in the presence of fibroblast growth factor 2 maintain the ability to differentiate and regenerate three-dimensional cartilaginous tissue. Exp Cell Res 1999, 253(2):681-688.
57. Martin I., Wendt D., et al. The role of bioreactors in tissue engineering. Trends Biotechnol 2004, 22(2):80-86.
58. Matsumoto K., Yoshitomi H., et al. Liver organogenesis promoted by endothelial cells prior to vascular function. Science 2001, 294(5542):559-563.
59. McGuigan, A. & Sefton, M. (2006). Vascularized organoid engineered by modular assembly enables blood perfusion. Submitted.
60. McLimans W. The gaseous environment of the mammalian cell in culture. Growth, Nutrition and Metabolism of Cells in Culture 1972, 137-170. Academic Press, New York. G. Rothblat, V. Cristofalo (Eds.).
61. Mendes S. Bone tissue-engineered implants using human bone marrow stromal cells: effect of culture conditions and donor age. Tiss Eng 2002, 8(6):911-920.
62. 2 consumption in monolayer cell cultures. Respir Physiol 1995, 100(2):10110-10116.
63. Moore G. Culture of Normal Human Leukocytes. JAMA 1967, 199:519-524.
64. Morgan J. The nutrition of animal cells in tissue culture. I. Initial studies on a synthetic medium. Proc Soc Exp Biol Med 1950, 73:1-8.
65. Muschler G.F., Nakamoto C., et al. Engineering principles of clinical cell-based tissue engineering. J Bone Joint Surg Am 2004, 86-A(7):1541-1558.
66. Nomi M., Atala A., et al. Principals of neovascularization for tissue engineering. Mol Aspects Med 2002, 23(6):463-483.
67. Obradovic B., Meldon J., et al. Glycosaminoglycan deposition in engineered cartilage: Experiments and mathematical model. AIChE J 2000, 46:1860-1871.
68. Ostrander R., Goomer R., et al. Donor cell fate in tissue engineering for articular cartilage repair. Clin Orthop 2001, 389:228-237.
69. Ozawa C.R., Banfi A., et al. Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. J Clin Invest 2004, 113(4):516-527.
70. Papadaki M., Bursac N., et al. Tissue engineering of functional cardiac muscle: molecular, structural, and electrophysiological studies. Am J Physiol Heart Circ Physiol 2001, 280(1):H168-H178.
71. Park Y., Lutolf M.P., et al. Bovine primary chondrocyte culture in synthetic matrix metalloproteinase-sensitive poly(ethylene glycol)-based hydrogels as a scaffold for cartilage repair. Tiss Eng 2004, 10(3-4):515-522.
72. Pilliar R. Porous-surfaced metallic implants for orthopedic applications. J Biomed Mater Res 1987, 21(A1 Suppl):1-33.
73. Radisic M., Deen W., et al. Mathematical model of oxygen distribution in engineered cardiac tissue with parallel channel array perfused with culture medium containing oxygen carriers. Am J Physiol Heart Circ Physiol 2005, 288(3):H1278-H1289.
74. Radisic M., Euloth M., et al. High-density seeding of myocyte cells for cardiac tissue engineering. Biotechnol Bioeng 2003, 82(4):403-414.
75. Radisic M., Malda J., et al. Oxygen gradients correlate with cell density and cell viability in engineered cardiac tissue. Biotechnol Bioeng 2006, 93(2):332-343.
76. Radisic M., Park H., et al. Biomimetic approach to cardiac tissue engineering: oxygen carriers in channeled scaffolds. Tissue Engineering 2006, 12:2077-2091.
77. Radisic M., Yang L., et al. Medium perfusion enables engineering of compact and contractile cardiac tissue. American Journal of Physiology: Heart and Circulatory Physiology 2004, 286:H507-H516.
78. Razaq S., Wilkins R.J., et al. The effect of extracellular pH on matrix turnover by cells of the bovine nucleus pulposus. Eur Spine J 2003, 12(4):341-349.
79. Ringer S. A further contribution regarding the influence of the different constituents of the blood on the contraction of the heart. J Physiol 1883, 4:29-43.
80. Sachlos E., Reis N., et al. Novel collagen scaffolds with predefined internal morphology made by solid freeform fabrication. Biomaterials 2003, 24(8):1487-1497.
81. Sengers B.G., Oomens C.W., et al. An integrated finite-element approach to mechanics, transport and biosynthesis in tissue engineering. J Biomech Eng 2004, 126(1):82-91.
82. Sengers B.G., van Donkelaar C.C., et al. Computational study of culture conditions and nutrient supply in cartilage tissue engineering. Biotechnol Prog 2005, 21(4):1252-1261.
83. Shinoka T., Ma P.X., et al. Tissue-engineered heart valves. Autologous valve leaflet replacement study in a lamb model. Circulation 1996, 94(9 Suppl):II164-II168.
84. Sikavitsas V.I., Bancroft G.N., et al. Mineralized matrix deposition by marrow stromal osteoblasts in 3D perfusion culture increases with increasing fluid shear forces. Proc Natl Acad Sci USA 2003, 100(25):14683-14688.
85. Sikavitsas V.I., Bancroft G.N., et al. Formation of three-dimensional cell/polymer constructs for bone tissue engineering in a spinner flask and a rotating wall vessel bioreactor. J Biomed Mater Res 2002, 62(1):136-148.
86. Strehl R., Schumacher K., et al. Proliferating cells versus differentiated cells in tissue engineering. Tiss Eng 2002, 8(1):37-42.
87. von Degenfeld G., Banfi A., et al. Myoblast-mediatedgene transfer for therapeutic angiogenesis and arteriogenesis. Br J Pharmacol 2003, 140(4):620-626.
88. Vunjak-Novakovic G., Freed L., et al. Effects of mixingon tissue engineered cartilage. AIChE J 1996, 42:850-860.
89. Vunjak-Novakovic G., Obradovic B., et al. Dynamic cell seeding of polymer scaffolds for cartilage tissue engineering. Biotechnol Prog 1998, 14(2):193-202.
90. Wang H.J., Pieper J., et al. Stimulation of skin repair is dependent on fibroblast source and presence of extracellular matrix. Tiss Eng 2004, 10(7-8):1054-1064.
91. White P. Cultivation of animal tissues in vitro in nutrients of known concentrations. Growth 1946, 10:231-289.
92. White P. J Cell Comp Physiol 1949, 34:221-241.
93. Woodfield T.B.F., Bezemer J.M., et al. Scaffolds for tissue engineering of cartilage. Crit Rev Eukaryot Gene Expr 2002, 12(3):209-236.
94. Yaeger P., Masi T., et al. Synergistic action of transforming growth factor-beta and insulin-like growth factor-I induces expression of type II collagen and aggrecan genes in adult human articular chondrocytes. Exp Cell Res 1997, 237(2):318-325.
95. Zigler J.S., Lepe-Zuniga J.L., et al. Analysis of the cytotoxic effects of light-exposed HEPES-containing culture medium. In Vitro Cell Dev Biol 1985, 21(5):282-287.
96. Zisch A.H., Lutolf M.P., et al. Cell-demanded release of VEGF from synthetic, biointeractive cell ingrowth matrices for vascularized tissue growth. Faseb J 2003, 17(15):2260-2262.
97. Zisch A.H., Lutolf M.P., et al. Biopolymeric deliverymatrices for angiogenic growth factors. Cardiovasc Pathol 2003, 12(6):295-310.